Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Mario Kahn

Showing results (31-40 of 41) with videos related to

Pageof 5
Sort By:
Proceedings of the National Academy of Sciences of the United States of America|January 20, 2023
Inhibition of <i>HSD17B13</i> protects against liver fibrosis by inhibition of pyrimidine catabolism in nonalcoholic steatohepatitisPanu K Luukkonen, Ikki Sakuma, Rafael C Gaspar, et al.
The Journal of Biological Chemistry|August 12, 2011
Influence of the hepatic eukaryotic initiation factor 2alpha (eIF2alpha) endoplasmic reticulum (ER) stress response pathway on insulin-mediated ER stress and hepatic and peripheral glucose metabolismAndreas L Birkenfeld, Hui-Young Lee, Sachin Majumdar, et al.
The Journal of Biological Chemistry|May 29, 2007
Suppression of diacylglycerol acyltransferase-2 (DGAT2), but not DGAT1, with antisense oligonucleotides reverses diet-induced hepatic steatosis and insulin resistanceCheol Soo Choi, David B Savage, Ameya Kulkarni, et al.
Biorxiv : the Preprint Server for Biology|March 10, 2025
Liver lipid droplet cholesterol content is a key determinant of metabolic dysfunction-associated steatohepatitisIkki Sakuma, Rafael C Gaspar, Ali R Nasiri, et al.
Hepatology (Baltimore, Md.)|November 24, 2012
Role of patatin-like phospholipase domain-containing 3 on lipid-induced hepatic steatosis and insulin resistance in ratsNaoki Kumashiro, Toru Yoshimura, Jennifer L Cantley, et al.
Cell Metabolism|September 4, 2020
A Membrane-Bound Diacylglycerol Species Induces PKCϵ-Mediated Hepatic Insulin ResistanceKun Lyu, Ye Zhang, Dongyan Zhang, et al.
Proceedings of the National Academy of Sciences of the United States of America|January 11, 2013
CGI-58 knockdown sequesters diacylglycerols in lipid droplets/ER-preventing diacylglycerol-mediated hepatic insulin resistanceJennifer L Cantley, Toru Yoshimura, Joao Paulo G Camporez, et al.
Proceedings of the National Academy of Sciences of the United States of America|May 1, 2025
Liver lipid droplet cholesterol content is a key determinant of metabolic dysfunction-associated steatohepatitisIkki Sakuma, Rafael C Gaspar, Ali R Nasiri, et al.
Cell Metabolism|December 1, 2009
Prevention of hepatic steatosis and hepatic insulin resistance by knockdown of cAMP response element-binding proteinDerek M Erion, Irena D Ignatova, Shin Yonemitsu, et al.
The Journal of Clinical Investigation|December 16, 2024
SGLT2 inhibition alters substrate utilization and mitochondrial redox in healthy and failing rat heartsLeigh Goedeke, Yina Ma, Rafael C Gaspar, et al.
Pageof 5

Showing results (31-40 of 41) with videos related to

Sort By:
Pageof 5
Proceedings of the National Academy of Sciences of the United States of America|January 20, 2023
Inhibition of <i>HSD17B13</i> protects against liver fibrosis by inhibition of pyrimidine catabolism in nonalcoholic steatohepatitisPanu K Luukkonen, Ikki Sakuma, Rafael C Gaspar, et al.
The Journal of Biological Chemistry|August 12, 2011
Influence of the hepatic eukaryotic initiation factor 2alpha (eIF2alpha) endoplasmic reticulum (ER) stress response pathway on insulin-mediated ER stress and hepatic and peripheral glucose metabolismAndreas L Birkenfeld, Hui-Young Lee, Sachin Majumdar, et al.
The Journal of Biological Chemistry|May 29, 2007
Suppression of diacylglycerol acyltransferase-2 (DGAT2), but not DGAT1, with antisense oligonucleotides reverses diet-induced hepatic steatosis and insulin resistanceCheol Soo Choi, David B Savage, Ameya Kulkarni, et al.
Biorxiv : the Preprint Server for Biology|March 10, 2025
Liver lipid droplet cholesterol content is a key determinant of metabolic dysfunction-associated steatohepatitisIkki Sakuma, Rafael C Gaspar, Ali R Nasiri, et al.
Hepatology (Baltimore, Md.)|November 24, 2012
Role of patatin-like phospholipase domain-containing 3 on lipid-induced hepatic steatosis and insulin resistance in ratsNaoki Kumashiro, Toru Yoshimura, Jennifer L Cantley, et al.
Cell Metabolism|September 4, 2020
A Membrane-Bound Diacylglycerol Species Induces PKCϵ-Mediated Hepatic Insulin ResistanceKun Lyu, Ye Zhang, Dongyan Zhang, et al.
Proceedings of the National Academy of Sciences of the United States of America|January 11, 2013
CGI-58 knockdown sequesters diacylglycerols in lipid droplets/ER-preventing diacylglycerol-mediated hepatic insulin resistanceJennifer L Cantley, Toru Yoshimura, Joao Paulo G Camporez, et al.
Proceedings of the National Academy of Sciences of the United States of America|May 1, 2025
Liver lipid droplet cholesterol content is a key determinant of metabolic dysfunction-associated steatohepatitisIkki Sakuma, Rafael C Gaspar, Ali R Nasiri, et al.
Cell Metabolism|December 1, 2009
Prevention of hepatic steatosis and hepatic insulin resistance by knockdown of cAMP response element-binding proteinDerek M Erion, Irena D Ignatova, Shin Yonemitsu, et al.
The Journal of Clinical Investigation|December 16, 2024
SGLT2 inhibition alters substrate utilization and mitochondrial redox in healthy and failing rat heartsLeigh Goedeke, Yina Ma, Rafael C Gaspar, et al.
Pageof 5